Mergers & Acquisitions (M&A) Activity OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform OptimizeRx, a provider of point-of-care technology solutions helping patients start and stay on therapy announced a definitive agreement to acquire the EvinceMed platform and related assets. EvinceMed is a provider in delivering end-to-end automation for specialty pharmaceutical transactions. The acquisition includes the full Market Access Management Platform
Read More
Digital phenotyping
Behavidence Raises $4.3M to Expand AI-Driven Psychiatric & Neurological Disorders Monitoring
What You Should Know: - Behavidence, a behavioral health company that monitors psychiatric and neurological disorders using artificial intelligence, announced a $4.3M seed round led by Welltech Ventures, featuring Arc Impact and Longevity Ventures. - Founded in 2020, Behavidence offers multiple digital phenotyping models that can predict disorders such as depression, anxiety, ADHD and more. These digital phenotyping solutions have been adopted by health organizations, tech, commercial and
Read More
Verily’s Onduo Virtual Care Solution Expands to Multi-Condition Platform
What You Should Know: - Verily's Onduo, known for its tech-based solution for virtual diabetes management, is launching a new multi-condition platform that matches the right care to the right consumer at the right time. The expanded virtual care platform is designed to support patients managing type 2 diabetes and hypertension, with plans for further expansion into mental and behavioral health.- In addition, Onduo has introduced multi-language support to make the virtual
Read More
8 Use Cases for Natural Language Processing (NLP) Technology in Healthcare
A look at natural language processing (NLP) technology's top potential use cases reveals how its destined to disrupt healthcare.It’s no secret that the big data wave had been building in healthcare for some time. What has somewhat remained a bit mysterious, however, is how innovators planned to stave the flood and make use of the sizeable data to help healthcare providers create efficiencies and improve outcomes. According to a recent Chilmark report, natural language processing (NLP) may be the
Read More
Mindstrong Health, Takeda Partner to Develop Digital Biomarkers for Mental Health Conditions
Mindstrong Health, a digital health startup transforming the diagnosis and treatment of neuropsychiatric disorders, has entered into a partnership with Takeda Pharmaceutical Company Limited to explore the development of digital biomarkers for selected mental health conditions, in particular schizophrenia and treatment-resistant depression.In this decade, neuropsychiatric disorders represent the largest source of medical disability for people under age 50. The costs are among the highest of all
Read More
